Literature DB >> 34924625

Staphylococcus lugdunensis as Cause of Septic Pericarditis.

Suha Abu Khalaf1, Abdallah Mansour2, Isma Perveze3, Belinda Fender3, Daniel R Walker3, Dima Dandachi1.   

Abstract

Staphylococcus lugdunensis (S. lugdunensis) is a coagulase-negative gram-positive bacterium, considered part of skin flora, which can simultaneously cause human diseases. S. lugdunensis has been reported in the literature as one of the causative agents for infective endocarditis.1 Although one of the coagulasenegative staphylococci, S. lugdunensis shares many virulent characteristics with Staphylococcus aureus (S. aureus), including biofilm formation. It has been associated with various foreign body-related infections such as prosthetic joint infections,2 in addition to bacteremia, osteomyelitis, septic arthritis, central nervous system, urinary tract infections, peritonitis, infective endocarditis and others. Given the association with severe and aggressive infections, it is important to treat S. lugdunensis as true infection rather than a contaminant, particularly in a suspect clinical context.3-6 Currently, there are no reported cases in the literature on pericarditis secondary to S. lugdunensis. We present a case of a 69-year-old woman with pericarditis, sepsis and disseminated intravascular coagulopathy (DIC) due to S. lugdunensis. Copyright 2021 by the Missouri State Medical Association.

Entities:  

Mesh:

Year:  2021        PMID: 34924625      PMCID: PMC8672951     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  15 in total

1.  Clinical significance of a single Staphylococcus lugdunensis-positive blood culture.

Authors:  Hind J Fadel; Robin Patel; Emily A Vetter; Larry M Baddour
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

2.  Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis.

Authors:  Ian H McHardy; Jennifer Veltman; Janet Hindler; Katia Bruxvoort; Marissa M Carvalho; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

3.  [Infection by Staphylococcus lugdunensis: clinico-microbiologic characterization of 25 cases].

Authors:  M J Ros; A Ramírez; E Arteaga; C Alberto; J Gil; J Reina
Journal:  Enferm Infecc Microbiol Clin       Date:  1999-05       Impact factor: 1.731

4.  In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States.

Authors:  David J Farrell; Rodrigo E Mendes; Mekki Bensaci
Journal:  Diagn Microbiol Infect Dis       Date:  2018-08-23       Impact factor: 2.803

5.  Clinical Characteristics and Outcomes of Staphylococcus lugdunensis Prosthetic Joint Infections: A Multicenter Retrospective Analysis.

Authors:  Komal Masood; Roberta E Redfern; Joan M Duggan; Gregory M Georgiadis; Geehan Suleyman
Journal:  Orthopedics       Date:  2020-10-01       Impact factor: 1.390

6.  Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients.

Authors:  D Souvenir; D E Anderson; S Palpant; H Mroch; S Askin; J Anderson; J Claridge; J Eiland; C Malone; M W Garrison; P Watson; D M Campbell
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

7.  Fulminant staphylococcus lugdunensis septicaemia following a pelvic varicella-zoster virus infection in an immune-deficient patient: a case report.

Authors:  M Woznowski; I Quack; E Bölke; M Peiper; C Matuschek; S G Gatermann; L C Rump; Gisela Schieren
Journal:  Eur J Med Res       Date:  2010-09-24       Impact factor: 2.175

Review 8.  Staphylococcus lugdunensis: Review of Epidemiology, Complications, and Treatment.

Authors:  Shridhar Parthasarathy; Shrey Shah; Avinaash Raja Sager; Anvitha Rangan; Satya Durugu
Journal:  Cureus       Date:  2020-06-24

9.  Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options.

Authors:  Lana Taha; Marc Stegger; Bo Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-05-29       Impact factor: 3.267

10.  Endocarditis due to Staphylococcus lugdunensis-a retrospective national registry-based study.

Authors:  Malin Hagstrand Aldman; Magnus Rasmussen; Lars Olaison; Lisa I Påhlman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-12-30       Impact factor: 3.267

View more
  1 in total

1.  Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies.

Authors:  Robert Root-Bernstein; Jack Huber; Alison Ziehl
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.